Commentary|Slideshows|February 8, 2025

Clinical Pearls: Inside the Mind of the Athlete

Author(s)H. Steven Moffic, MD, Mena Mirhom, MD, FAPA, Wilsa M.S. Charles Malveaux, MD, MA, FAPA

With the Super Bowl highlighting elite athletic performance, sports psychiatry is essential in strengthening athletes' mental resilience and well-being.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Related Content

Invisible Ranks: The Untold Battle for Women Veterans’ Mental Health

ByRodney Villanueva, MD,Morgan Wan, MD,Liliana Gonzalez-Cabrales, MD

November 11th 2025

Women Are Diagnosed With ADHD 5 Years Later Than Men

ByLeah Kuntz

October 13th 2025

Sleep as Connective Tissue: Quantifying Team Dynamics in Elite Sports

ByDerek H. Suite, MD, MS,Mena Mirhom, MD, FAPA

October 9th 2025

Is There a ‘War on Women’ Department?

ByH. Steven Moffic, MD

October 3rd 2025

Developing Resilience in Patients

ByRoss Flowers, PhD

September 15th 2025

Latest CME

In-Person + Virtual Event

Real Psychiatry 2026

January 23-24, 2026

Video

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Video

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Video

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Clinical Pearls: Inside the Mind of the Athlete

Newsletter

Related Content

Invisible Ranks: The Untold Battle for Women Veterans’ Mental Health

Women Are Diagnosed With ADHD 5 Years Later Than Men

Sleep as Connective Tissue: Quantifying Team Dynamics in Elite Sports

Is There a ‘War on Women’ Department?

Developing Resilience in Patients

Latest CME

Real Psychiatry 2026

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Optimizing Care for Patients With Tardive Dyskinesia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

The Concept of Mental Illness, and Why the DSM Approach Is Wrong

Psychedelic PSX-001 for Generalized Anxiety Disorder: A Conversation With Lou Barbato, MD

Okie Tokie Talk: Adolescent Cannabis Use in Oklahoma, the Sooner State

Quantifying Generative AI Use for Mental Health Advice Among Adolescents

Data Presentation on XPro1595 for Alzheimer Disease With Inflammation at CTAD